Cellerys AG
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis (NCT06430671) | Cellerys AG | 2024-06-18 |
Track Cellerys AG automatically
Every clearance here is in the API, with alerts when new ones post.